Welcome to Clinical Perspectives, a new column from Mommy Matters. We cull the newest, most important pregnancy and postpartum news and break it down into a few takeaway points you need to know. Also, we have our own medical expert, Dr. Shirazian, who reviews each article and adds the clinical perspective. If you are interested in learning more on your own, our MD-trusted sources include the American College of Obstetricians and Gynecologists, American Academy of Pediatrics, and Very Well Health.
July 25, 2019 - Global pharmaceutical company Allergan has issued a voluntary U.S. recall of its BIOCELL textured breast implants and tissue expander products due to increased rates of breast implant-related cancers.
- The recall was announced following the FDA’s July 24th global safety update on uncommon incidences of Allergan breast implant-associated cancer, specifically anaplastic large cell lymphoma (BIA-ALCL).
- Textured breast implants currently make up less than 5% of all breast implants sold in the U.S.
- The FDA and other health authorities do not currently recommend that asymptomatic people with BIOCELL or other textured breast implants or expanders undergo removal or replacement.
- The full list of recalled products can be found at the FDA’s website.
- If you are interested in receiving breast implants, the FDA advises discussing the risks and benefits of available implant types with your plastic surgeon.
You can read the FDA’s press release here.
Disclaimer: This is general medical information and not specific medical advice. It does not and should not replace diagnosis or treatment by your healthcare provider. If you are seeking personal recommendations, advice, and/or treatment, please consult your physician. If you have an emergency, you should contact 911 or go to the nearest Emergency Room.